DiscoverFirstTake on Pharma - Pharma News and Analysis PodcastThe First Take – Pharma's pandemic takes a new twist
The First Take – Pharma's pandemic takes a new twist

The First Take – Pharma's pandemic takes a new twist

Update: 2021-12-03
Share

Description

FirstWord Pharma PLUS editors Matthew Dennis and Simon King discuss the potential impact of the Omicron variant on the efficacy of COVID-19 vaccines, how GlaxoSmithKline and Sanofi are making moves to keep their vaccines portfolios at the cutting edge of R&D and whether there is a meaningful future for Merck & Co.’s COVID-19 antiviral molnupiravir after this week’s close-run AdCom vote.
Comments 
In Channel
loading
00:00
00:00
x

0.5x

0.8x

1.0x

1.25x

1.5x

2.0x

3.0x

Sleep Timer

Off

End of Episode

5 Minutes

10 Minutes

15 Minutes

30 Minutes

45 Minutes

60 Minutes

120 Minutes

The First Take – Pharma's pandemic takes a new twist

The First Take – Pharma's pandemic takes a new twist

FirstWord Pharma